MOSEDA TECHNOLOGIES WKN: A2AJTB ISIN: CA75955T1030 Kürzel: RHT Forum: Aktien Thema: Hauptdiskussion

Ich habe 50.000 stk Glaube an das Konzept und bin bei 0,12€ eingestiegen. Halte die Aktie bis ohne wenn und aber

Im Google Play Store hat die iUGO App außerdem “mehr als 50.000 Downloads“. Könnte auch dafür sprechen...

Die Zahlen hängen im Wesentlichen von der Nutzerzahl der iUGO Plattform ab und da das Sales-Team verstärkt und ein CRM implementiert wurde, gehe ich davon aus, dass die aktuelle Nutzerzahl höher als erwartet ausfällt. Das Produkt ist einfach stark. Halte aktuell 4.000 Stück. Du?

Was ist bei dir ordentlich? Wieviel Stück hälst du?

Deckt euch schon mal ein. Kann mir gut vorstellen, dass die Quartalszahlen wieder ordentlich ausfallen.

Reliq Health Technologies Inc. (RHT.V) (RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, will host an investor update conference call on May 31, 2018 to review the Company’s recent progress and answer questions from shareholders. The Company would also like to inform shareholders that it will be releasing its quarterly financial statements for Q3 FY2018 (January 1, 2018 – March 31, 2018) on May 30, 2018. Conference Call Information: When:May 31, 2018, 8:00am – 9:00am PST / 11:00am – noon ESTID:9284748Dial In:Canada and U.S. – (844) 461-9931International – (636) 812-6630 The Company would like to advise participants to join the conference call at least 10 minutes early in order to register. Investors are encouraged to submit questions in advance to info@reliqhealth.com as these questions will be addressed first, following which the moderator will open up the call to questions from investors who have registered and joined the queue. To join the queue participants will be asked to key in *1 at any point in the call. Once the questions submitted in advance via email have been addressed, the moderator will open the line to callers in the queue one at a time in order of priority. A recording of the conference call will be available afterwards until June 7, 2018, and will be accessible by calling either of the following numbers: (855) 859-2056 or (404) 537-3406. ON BEHALF OF THE BOARD “Dr. Lisa Crossley” CEO and Director

Hab hier jetzt nochmal nachgelegt zu dem Preis. Ist meiner Meinung nach stark unterbewertet auf Jahressicht.

@Elite: Das ist echt bitter... aber bei dem damaligen Kursverlauf vollkommen verständlich, dass man die nicht unbedingt hält.

Vor 3 Jahren mal die Aktie zu 0.14 EUR besessenen -.- damals noch unter dem Namen moseda. Schön wär's gewesen -.-

etwas still hier geworden

ja bitte @Kapital alle Infos hierher

Sehr gerne :) solche Infos können Gold Wert sein;)

Ich stehe direkt in Kontakt zu Lisa und Teile gerne meine Informationen wenn es gewünscht wird!

Du hattest wohl Recht, nicht schlecht. Die scheinen wirklich solide Arbeit zu machen und denken langfristig.

Patient Enrollment The Company has now onboarded over 12,000 patients and is continuing to add at least 2,000 new patients per month to the platform. Company Evolution and Expansion Reliq has undergone significant positive internal change over the last three months to enable accelerated growth going forward.  This quarter the Company: Hired an experienced Sales team consisting of three senior sales staff with a proven track record of generating more than $200M in sales of healthcare IT solutions.  The Sales team will be in place by mid-April, allowing the Company to accelerate growth through both the existing pipeline leads and new opportunities. Implemented a new Custom Relationship Management (CRM) system to improve lead tracking and reduce sales cycles. Expanded the Implementation team to support new client deployments. Migrated the iUGO Care platform code from a Toronto-based contract development provider to assume full ownership and control over the Company’s proprietary source code. Built an internal Technical Leadership team to own and manage the Company’s code and direct all future Development efforts. Expanded the Development team substantially while simultaneously reducing Development costs by engaging a highly respected, experienced contract development firm in Costa Rica. Expanded the Finance team and is in the process of engaging new auditors. Hired an Investor Relations resource to start in April to improve shareholder access to company information.  To contact Investor Relations please email IR@reliqhealth.com. To streamline the customer acquisition, client onboarding and patient enrollment processes the Company: Opened a US office in McAllen, Texas to provide a base for the Sales team. Added practice management and workflow support tools to the platform to provide clients with a turnkey solution for their organizations. Created off-the-shelf training materials for new clients and patients including videos, online tutorials and printed materials. Implemented automated claims submission to Medicare, Medicaid and private insurers. Financial Position On January 9th, 2018 the Company successfully closed an oversubscribed private placement led by Canaccord Genuity Corp and Gravitas Securities Inc. with gross proceeds of approximately $10,000,000. Reliq currently has $13 Million CAD in cash and cash equivalents

Hier eine Nachricht von Reliq Bin gespannt ob Donnerstag die Neuigkeiten kommen We don’t have a formal plan for entering the German market at this point but we’re very interested in exploring potential opportunities in Europe later this year. The share price is down because the market is volatile right now, but we’ll be issuing a corporate update news release on Thursday that should rebuild our momentum. Thanks, Lisa